Literature DB >> 20428916

Complete remission of non-HIV collapsing glomerulopathy with deflazacort and lisinopril in an adult patient.

Jorge Vega1, Francisco Javier Guarda, Helmuth Goecke, Gonzalo P Méndez.   

Abstract

Collapsing glomerulopathy is a form of focal segmental glomerulosclerosis that is usually associated with HIV-1 infection, and is characterized by its poor prognosis and almost inevitable progression to end-stage renal disease. Its pathological features include collapsed glomeruli, podocyte hypertrophy and hyperplasia, and pseudocrescents. This case report shows the evolution of a 58-year-old patient with non-HIV idiopathic collapsing glomerulopathy who presented with severe nephrotic syndrome and renal insufficiency and was treated with lisinopril and deflazacort, a synthetic corticosteroid that has shown fewer cosmetic effects and glucose and bone metabolism complications than prednisone. The patient responded with full recovery of renal function and normal range of protein excreted in urine after less than two years of treatment. The patient has not suffered a recurrence of his nephrotic syndrome after three years of steroid withdrawal. There is no proven therapy for collapsing glomerulopathy, and this case highlights an alternative for treating this disease with few secondary effects.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20428916     DOI: 10.1007/s10157-010-0284-1

Source DB:  PubMed          Journal:  Clin Exp Nephrol        ISSN: 1342-1751            Impact factor:   2.801


  16 in total

1.  Deflazacort: towards selective glucocorticoid receptor modulation?

Authors:  B R Walker
Journal:  Clin Endocrinol (Oxf)       Date:  2000-01       Impact factor: 3.478

Review 2.  Collapsing glomerulopathy.

Authors:  Mamdouh Albaqumi; Timothy J Soos; Laura Barisoni; Peter J Nelson
Journal:  J Am Soc Nephrol       Date:  2006-08-16       Impact factor: 10.121

Review 3.  Collapsing glomerulopathy.

Authors:  Joshua A Schwimmer; Glen S Markowitz; Anthony Valeri; Gerald B Appel
Journal:  Semin Nephrol       Date:  2003-03       Impact factor: 5.299

Review 4.  Current views on collapsing glomerulopathy.

Authors:  Mamdouh Albaqumi; Laura Barisoni
Journal:  J Am Soc Nephrol       Date:  2008-02-20       Impact factor: 10.121

5.  Glucocorticoid-induced osteoporosis in the lumbar spine, forearm, and mandible of nephrotic patients: a double-blind study on the high-dose, long-term effects of prednisone versus deflazacort.

Authors:  K Olgaard; T Storm; N van Wowern; H Daugaard; M Egfjord; E Lewin; L Brandi
Journal:  Calcif Tissue Int       Date:  1992-06       Impact factor: 4.333

6.  Nephrotic syndrome, progressive irreversible renal failure, and glomerular "collapse": a new clinicopathologic entity?

Authors:  M A Weiss; E Daquioag; E G Margolin; V E Pollak
Journal:  Am J Kidney Dis       Date:  1986-01       Impact factor: 8.860

7.  Focal segmental glomerulosclerosis in nephrotic adults: presentation, prognosis, and response to therapy of the histologic variants.

Authors:  Micky J Chun; Stephen M Korbet; Melvin M Schwartz; Edmund J Lewis
Journal:  J Am Soc Nephrol       Date:  2004-08       Impact factor: 10.121

Review 8.  Collapsing glomerulopathy--a new pattern of renal injury.

Authors:  Arvydas Laurinavicius; Helmut G Rennke
Journal:  Semin Diagn Pathol       Date:  2002-08       Impact factor: 3.464

Review 9.  Collapsing glomerulopathy: an inflammatory podocytopathy?

Authors:  Laura Barisoni; Peter J Nelson
Journal:  Curr Opin Nephrol Hypertens       Date:  2007-05       Impact factor: 2.894

10.  Pharmacokinetic/pharmacodynamic evaluation of deflazacort in comparison to methylprednisolone and prednisolone.

Authors:  H Möllmann; G Hochhaus; S Rohatagi; J Barth; H Derendorf
Journal:  Pharm Res       Date:  1995-07       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.